Hyperthermic Intraperitonial Chemotherapy: Clinical Trials

1 trial of Hyperthermic Intraperitonial Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Hyperthermic Intraperitonial Chemotherapy: new trials by email Literature Review of Hyperthermic Intraperitonial Chemotherapy trials Research Report on Hyperthermic Intraperitonial Chemotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Sodium Thiosulfate, 5-Fluorouracil, Oxaliplatin - Peritoneal Mesothelioma, Peritoneal Carcinomatosis
Phase 1RecruitingNational Cancer Institute (NCI)602021-10-192026-10-16

Conditions studied

Appendiceal Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Necrosis (1)  ·  Ovarian Neoplasms (1)  ·  Peritoneal Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

Andrew M Blakely, M.D. (1)